Association Between Arsenic Toxicity, AS3MT Gene Polymorphism and Onset of Type 2 Diabetes.
AS3MT gene
Arsenic toxicity
Drinking water
Type 2 diabetes
Water contamination
Journal
Biological trace element research
ISSN: 1559-0720
Titre abrégé: Biol Trace Elem Res
Pays: United States
ID NLM: 7911509
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
received:
22
08
2023
accepted:
13
10
2023
medline:
27
10
2023
pubmed:
27
10
2023
entrez:
27
10
2023
Statut:
aheadofprint
Résumé
Arsenic (As) exposure in drinking water has become a serious public health issue. AS3MT gene is involved in the metabolism of arsenic, so a single nucleotide polymorphism in this gene may lead to the development of type 2 diabetes in arsenic-exposed areas. This study aimed to evaluate the association of the AS3MT gene with the development of type 2 diabetes in highly arsenic-exposed areas of Punjab, Pakistan. Total 200 samples equal in number from high arsenic exposed-areas of Lahore (Nishtar) and Kasur (Mustafa Abad) were collected. rs11191439 was utilized as an influential variable to evaluate the association between arsenic metabolism and diabetes status to find a single nucleotide polymorphism in the AS3MT gene. We observed the arsenic level in drinking water of the arsenic-exposed selected areas 115.54 ± 1.23 µg/L and 96.88 ± 0.48 µg/L, respectively. The As level in the urine of diabetics (98.54 ± 2.63 µg/L and 56.38 ± 12.66 µg/L) was higher as compared to non-diabetics (77.58 ± 1.8 µg/L and 46.9 ± 8.95 µg/L) of both affected areas, respectively. Correspondingly, the As level in the blood of diabetics (6.48 ± 0.08 µg/L and 5.49 ± 1.43 µg/L) and non-diabetics (6.22 ± 0.12 µg/L and 5.26 ± 0.24 µg/L) in the affected areas. Genotyping showed significant differences in the frequencies of alleles among cases and controls. Nevertheless, notable disparities in genotype distribution were observed in SNPs rs11191439 (T/C) (P < 0.05) and when comparing T2D patients and non-diabetic control subjects. The AS3MT gene and clinical parameters show a significant association with the affected people with diabetes living in arsenic-exposed areas.
Identifiants
pubmed: 37889428
doi: 10.1007/s12011-023-03919-2
pii: 10.1007/s12011-023-03919-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Hendryx M, Luo J, Chojenta C, Byles JE (2021) Exposure to heavy metals from point pollution sources and risk of incident type 2 diabetes among women: a prospective cohort analysis. Int J Environ Health Res 31(4):453–464
doi: 10.1080/09603123.2019.1668545
pubmed: 31533451
Shaji E, Santosh M, Sarath KV, Prakash P, Deepchand V, Divya BV (2021) Arsenic contamination of groundwater: a global synopsis with focus on the Indian Peninsula. Geosci Front 12(3):101079
doi: 10.1016/j.gsf.2020.08.015
Niazi NK, Bibi I, Shahid M, Ok YS, Burton ED, Wang H, ... Lüttge A (2018) Arsenic removal by perilla leaf biochar in aqueous solutions and groundwater: an integrated spectroscopic and microscopic examination. Environ Pollut 232:31–41
Huq ME, Fahad S, Shao Z, Sarven MS, Khan IA, Alam M, ... Khan WU (2020) Arsenic in a groundwater environment in Bangladesh: occurrence and mobilization. J Environ Manag 262:110318
Shen H, Niu Q, Xu M, Rui D, Xu S, Feng G, ... Jing M (2016) Factors affecting arsenic methylation in arsenic-exposed humans: a systematic review and meta-analysis. Int J Environ Res Public Health 13(2):205
Rangel-Moreno K, Gamboa-Loira B, López-Carrillo L, Cebrián ME (2022) Prevalence of type 2 diabetes mellitus in relation to arsenic exposure and metabolism in Mexican women. Environ Res 210:112948
doi: 10.1016/j.envres.2022.112948
pubmed: 35189103
Signes-Pastor AJ, Gutiérrez-González E, Garcia-Villarino M, Rodríguez-Cabrera FD, López-Moreno JJ, Varea-Jiménez E, ... Karagas MR (2021) Toenails as a biomarker of exposure to arsenic: a review. Environ Res 195:110286
Abdul KSM, Jayasinghe SS, Chandana EP, Jayasumana C, De Silva PMC (2015) Arsenic and human health effects: a review. Environ Toxicol Pharmacol 40(3):828–846
doi: 10.1016/j.etap.2015.09.016
pubmed: 26476885
Ji JH, Jin MH, Kang JH, Lee SI, Lee S, Kim SH, Oh SY (2021) Relationship between heavy metal exposure and type 2 diabetes: a large-scale retrospective cohort study using occupational health examinations. BMJ Open 11(3):e039541
doi: 10.1136/bmjopen-2020-039541
pubmed: 33664065
pmcid: 7934714
Misra BB, Misra A (2020) The chemical exposome of type 2 diabetes mellitus: opportunities and challenges in the omics era. Diabetes Metab Syndr 14(1):23–38
doi: 10.1016/j.dsx.2019.12.001
pubmed: 31838434
Grau-Perez M, Kuo CC, Gribble MO, Balakrishnan P, Jones Spratlen M, Vaidya D, ... Navas-Acien A (2017. Association of low-moderate arsenic exposure and arsenic metabolism with incident diabetes and insulin resistance in the Strong Heart Family Study. Environ Health Perspect 125(12):127004
Mendez MA, González-Horta C, Sánchez-Ramírez B, Ballinas-Casarrubias L, Cerón RH, Morales DV, ... Stýblo M (2016) Chronic exposure to arsenic and markers of cardiometabolic risk: a cross-sectional study in Chihuahua, Mexico. Environ Health Perspect 124(1):104–111
Bommarito PA, Beck R, Douillet C, Del Razo LM, Garcia-Vargas GG, Valenzuela OL, ... Fry RC (2019) Evaluation of plasma arsenicals as potential biomarkers of exposure to inorganic arsenic. J Expo Sci Environ Epidemiol 29(5):718–729
Drobna Z, Naranmandura H, Kubachka KM, Edwards BC, Herbin-Davis K, Styblo M, ... Le XC (2009) Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem Res Toxicol 22(10):1713–1720
Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, ... Thayer KA (2012). Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect 120(12):1658–1670
Tseng CH (2004) The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol 197(2):67–83
doi: 10.1016/j.taap.2004.02.009
pubmed: 15163543
Agusa T, Fujihara J, Takeshita H, Iwata H (2011) Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int J Mol Sci 12(4):2351–2382
doi: 10.3390/ijms12042351
pubmed: 21731446
pmcid: 3127122
Nuvolone D, Stoppa G, Petri D, Voller F (2023) Long-term exposure to low-level arsenic in drinking water is associated with cause-specific mortality and hospitalization in the Mt. Amiata area (Tuscany, Italy). BMC Public Health 23(1):71
doi: 10.1186/s12889-022-14818-x
pubmed: 36627610
pmcid: 9832768
Amir M, Asghar S, Ahsin M, Hussain S, Ismail A, Riaz M, Naz S (2021) Arsenic exposure through drinking groundwater and consuming wastewater-irrigated vegetables in Multan, Pakistan. Environ Geochem Health 43(12):5025–5035
doi: 10.1007/s10653-021-00940-z
pubmed: 33891257
González-Martínez F, Sánchez-Rodas D, Varela NM, Sandoval CA, Quiñones LA, Johnson-Restrepo B (2020) As3MT and GST polymorphisms influencing arsenic metabolism in human exposure to drinking groundwater. Int J Mol Sci 21(14):4832
doi: 10.3390/ijms21144832
pubmed: 32650499
pmcid: 7402318
Sambrook J, Fritsch ER, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Xu Y, Wang A, Lin X, Xu J, Shan Y, Pan X, Shan PF (2021) Global burden and gender disparity of vision loss associated with diabetes retinopathy. Acta Ophthalmol 99(4):431–440
doi: 10.1111/aos.14644
pubmed: 33124190
Simayi A, Mohemaiti P (2019) Risk and protective factors of co-morbid depression in patients with type 2 diabetes mellitus: a metaanalysis. Endocr J 66(9):793–805
doi: 10.1507/endocrj.EJ18-0579
pubmed: 31178523
Zhang Y, Tong M, Wang B, Shi Z, Wang P, Li L, ... Lu T (2021) Geographic, gender, and seasonal variation of diabetes: a nationwide study with 1.4 million participants. J Clin Endocrinol Metabol 106(12):e4981–e4992
Nayak BS, Sobrian A, Latiff K, Pope D, Rampersad A, Lourenço K, Samuel N (2014) The association of age, gender, ethnicity, family history, obesity and hypertension with type 2 diabetes mellitus in Trinidad. Diabetes Metab Syndr 8(2):91–95
doi: 10.1016/j.dsx.2014.04.018
pubmed: 24907173
Gao C, Sun X, Lu L, Liu F, Yuan J (2019) Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis. J Diabetes Investig 10(1):154–162
doi: 10.1111/jdi.12854
pubmed: 29683557
Ren X, Chen ZA, Zheng S, Han T, Li Y, Liu W, Hu Y (2016) Association between triglyceride to HDL-C ratio (TG/HDL-C) and insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus. PLoS One 11(4):e0154345
doi: 10.1371/journal.pone.0154345
pubmed: 27115999
pmcid: 4846162
Ezema GO, Omeh NY, Egbachukwu S, Agbo EC, Ikeyi AP, Obeagu EI (2023) Evaluation of biochemical parameters of patients with type 2 diabetes mellitus based on age and gender in Umuahia. Asian J Dent Health Sci 3(2):32–36
doi: 10.22270/ajdhs.v3i2.43
Pánico P, Velasco M, Salazar AM, Picones A, Ortiz-Huidobro RI, Guerrero-Palomo G, ... Hiriart M (2022) Is arsenic exposure a risk factor for metabolic syndrome? A review of the potential mechanisms. Front Endocrinol 13:878280
Klisic A, Kavaric N, Vujcic S, Mihajlovic M, Zeljkovic A, Ivanisevic J, ... Vekic J (2020) Inverse association between serum endocan levels and small LDL and HDL particles in patients with type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci 24(15)
Artha IMJR, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, ... Rina IK (2019) High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag 149–157
Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, ... Ridker PM (2018) Rationale and design of the pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes (PROMINENT) study. Am Heart J 206:80–93
Lee EY, Yang HK, Lee J, Kang B, Yang Y, Lee SH, ... Cho JH (2016) Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis 15(1):1–7
Alqahtani SAM, Awan ZA, Alasmary MY, Al Amoudi SM (2022) Association between serum uric acid with diabetes and other biochemical markers. J Fam Med Prim Care 11(4):1401
doi: 10.4103/jfmpc.jfmpc_1833_21
Ji P, Zhu J, Feng J, Li H, Yu Q, Qin H, Zhang J (2022) Serum uric acid levels and diabetic kidney disease in patients with type 2 diabetes mellitus: a dose-response meta-analysis. Prim Care Diabetes 16(3):457–465
doi: 10.1016/j.pcd.2022.03.003
pubmed: 35305901
Suijk DL, van Baar MJ, van Bommel EJ, Iqbal Z, Krebber MM, Vallon V, ... van Raalte DH (2022) SGLT2 inhibition and uric acid excretion in patients with type 2 diabetes and normal kidney function. Clin J Am Soc Nephrol 17(5):663–671
Rehman K, Fatima F, Akash MSH (2019) Biochemical investigation of association of arsenic exposure with risk factors of diabetes mellitus in Pakistani population and its validation in animal model. Environ Monit Assess 191:1–15
doi: 10.1007/s10661-019-7670-2
Lu J, Yu K, Fan S, Liu W, Dong Z, Li J, ... Zhou J (2019) Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide. Toxicol Appl Pharmacol 379:114687
Fujihara J, Soejima M, Koda Y, Kunito T, Takeshita H (2008) Asian specific low mutation frequencies of the M287T polymorphism in the human arsenic (+ 3 oxidation state) methyltransferase (AS3MT) gene. Mutat Res/Genet Toxicol Environ Mutagen 654(2):158–161
doi: 10.1016/j.mrgentox.2008.06.001
Lu J, Hu S, Wang W, Li J, Dong Z, Zhou J, Hai X (2018) AS3MT polymorphisms, arsenic metabolism, and the hematological and biochemical values in APL patients treated with arsenic trioxide. Toxicol Sci 166(1):219–227
doi: 10.1093/toxsci/kfy210
pubmed: 30376134